DIVA Laboratories Ltd
DIVA Laboratories, Ltd. engages in the development, manufacture, and sale of medical equipment and computer related devices worldwide. The company provides endo/surgical displays, a static and dynamic image for hybrid and integrated ORs applications; color and mono displays for radiology and medical imaging applications; touch displays/human machine interface products; medical and industrial case… Read more
DIVA Laboratories Ltd (4153) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.053x
Based on the latest financial reports, DIVA Laboratories Ltd (4153) has a cash flow conversion efficiency ratio of 0.053x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$51.94 Million) by net assets (NT$984.76 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
DIVA Laboratories Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how DIVA Laboratories Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
DIVA Laboratories Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DIVA Laboratories Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Big Sunshine Co Ltd
TW:1475
|
0.049x |
|
TJ media Co. Ltd
KQ:032540
|
-0.037x |
|
Telomir Pharmaceuticals, Inc. Common Stock
NASDAQ:TELO
|
-0.133x |
|
New Delhi Television Limited
NSE:NDTV
|
1.199x |
|
PT Wijaya Karya (Persero) Tbk
F:5AA
|
0.007x |
|
Taiwan Name Plate Co. Ltd.
TWO:6593
|
0.002x |
|
H.H.Galaxy Co., Ltd.
TWO:2949
|
-0.215x |
|
Green Cross Medical Science Corporation
KQ:142280
|
0.090x |
Annual Cash Flow Conversion Efficiency for DIVA Laboratories Ltd (2017–2024)
The table below shows the annual cash flow conversion efficiency of DIVA Laboratories Ltd from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$1.06 Billion | NT$123.14 Million | 0.117x | -52.36% |
| 2023-12-31 | NT$1.03 Billion | NT$252.91 Million | 0.245x | +240.01% |
| 2022-12-31 | NT$1.02 Billion | NT$73.19 Million | 0.072x | +723.74% |
| 2021-12-31 | NT$986.42 Million | NT$-11.39 Million | -0.012x | +31.40% |
| 2020-12-31 | NT$988.89 Million | NT$-16.64 Million | -0.017x | -136.22% |
| 2019-12-31 | NT$1.13 Billion | NT$52.66 Million | 0.046x | -36.04% |
| 2018-12-31 | NT$1.18 Billion | NT$86.02 Million | 0.073x | +41.41% |
| 2017-12-31 | NT$806.75 Million | NT$41.45 Million | 0.051x | -- |